RPS6 and neoplasm: Of note, the tumor revealed a strong immunohistochemical expression of not only mTOR but also its two main target proteins of the mTOR complex 1 by use of phosphorylation-specific antibodies against the active forms of the proteins, i.e., p‐4EBP1 and p‐RPS6.